Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Virtus Enters Into Firm Deal With CapVest

The Panel Joins CapVest In Virtus' Corner

Virtus Health (VRT AU): CapVest's Bid Edges BGH Capital

BGH Lodges Application With The Takeovers Panel Over CapVest's Bid for Virtus

Quiddity Advisors

Event-Driven

<ul>
<li>CapVest was clearly prepared. One day after <strong><a href="https://www.smartkarma.com/entities/virtus-health-ltd" target="_blank" data-smartkarma-citation="entities:14776:1" rel="noopener">Virtus Health (VRT AU)</a></strong> received a revised non-binding bid from BGH Capital of $7.65/share, CapVest bumped to $7.80 by way of a Scheme.</li>
<li>An off-market takeover bid with a minimum 50.1% minimum acceptance condition, offering $7.70/shares was also tabled by CapVest. </li>
<li>Virtus has pivoted to CapVest and will not engage with BGH as to its A$7.65/share Offer.</li>
</ul>


CapVest was clearly prepared. One day after Virtus Health (VRT AU) received a revised non-binding bid from BGH Capital of $7.65/share, CapVest bumped to $7.80 by way of a Scheme.
An off-market takeover bid with a minimum 50.1% minimum acceptance condition, offering $7.70/shares was also tabled by CapVest. 
Virtus has pivoted to CapVest and will not engage with BGH as to its A$7.65/share Offer.


Virtus Health Backs CapVest's Revised Bid